Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2025-12-26
Product name
FLAT CLEAR URETHANE POLYESTER
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-888-774-2001
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H335, H372
Hazard statements
Code
Statements
H335
May cause respiratory irritation
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
63.3% (oral), 95.6% (dermal), 55.5% (inhalation)
Signal word
Danger
Hazard statements
May cause respiratory irritation. Causes damage to organs through prolonged or repeated exposure. (lungs) May form combustible dust concentrations in air.
Prevention
Use only outdoors or in a well-ventilated area. Do not breathe dust or mist. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
Get medical advice or attention if you feel unwell. IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell.
Storage
Store locked up. Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Keep container tightly closed. Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Prevent dust accumulation. Emits toxic fumes when heated.
2.3 Other hazards
Fine dust clouds may form explosive mixtures with air. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 63.3% (oral), 95.6% (dermal), 55.5% (inhalation)